Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,320
datasets available to search
ShareScore release 0.9.0
Dataset results
1,320 results for “degeneration”
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01397409. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov study NCT04522167. IPD Sharing: NO. Countries: 9. Publications: 1.
ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01213082. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00320788. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Compare SB15 (Proposed Aflibercept Biosimilar) to Eylea in Subjects With Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT04450329. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation
ClinicalTrials.gov study NCT03478865. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration
ClinicalTrials.gov study NCT00716586. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration
ClinicalTrials.gov study NCT03677934. IPD Sharing: YES. Countries: 1. Publications: 7.
S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000
ClinicalTrials.gov study NCT00784225. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
ClinicalTrials.gov study NCT02581891. IPD Sharing: Not stated. Countries: 8. Publications: 5.
Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration
ClinicalTrials.gov study NCT00539734. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
ClinicalTrials.gov study NCT00593450. IPD Sharing: YES. Countries: 1. Publications: 47.
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
ClinicalTrials.gov study NCT03823300. IPD Sharing: YES. Countries: 21. Publications: 4.
Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
ClinicalTrials.gov study NCT00284089. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT00433017. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
ClinicalTrials.gov study NCT02305238. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration
ClinicalTrials.gov study NCT01089517. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)
ClinicalTrials.gov study NCT00509795. IPD Sharing: Not stated. Countries: 2. Publications: 3.
20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT01175395. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sirolimus for Advanced Age-Related Macular Degeneration
ClinicalTrials.gov study NCT01445548. IPD Sharing: Not stated. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.